{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:37:56Z","timestamp":1759412276214,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.vaccine.2021.10.052","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T14:32:23Z","timestamp":1638455543000},"page":"7319-7320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["BCG versus rBCG: What is the way forward?"],"prefix":"10.1016","volume":"39","author":[{"given":"C. Fordham","family":"von Reyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.10.052_b0005","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.3389\/fmicb.2019.03154","article-title":"Clinical development of new TB vaccines: Recent advances and next steps","volume":"10","author":"Hatherill","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2021.10.052_b0010","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1016\/j.vaccine.2021.09.040","article-title":"Recombinant BCGs for tuberculosis and bladder cancer","volume":"39","author":"Singh","year":"2021","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2021.10.052_b0015","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.052_b0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","article-title":"Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study","volume":"16","author":"Nguipdop-Djomo","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2021.10.052_b0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/0141076817732965","article-title":"Correcting the record on BCG before we license new vaccines against tuberculosis","volume":"110","author":"von Reyn","year":"2017","journal-title":"J R Soc Med"},{"key":"10.1016\/j.vaccine.2021.10.052_b0030","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.1983.03330410048027","article-title":"The BCG controversy: a methodological and statistical reappraisal","volume":"249","author":"Clemens","year":"1983","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2021.10.052_b0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/cid\/ciu331","article-title":"BCG, latitude and environmental mycobacteria","volume":"59","author":"von Reyn","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2021.10.052_b0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: A systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"43","key":"10.1016\/j.vaccine.2021.10.052_b0045","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"Knight","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.052_b0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:07:28Z","timestamp":1759403248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21013852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":10,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0264410X21013852"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG versus rBCG: What is the way forward?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.040","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}